Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miranush Saaryan"'
Autor:
Lusine Harutyunyan, Anahit Ter-Grigoryan, Hayk Grigoryan, Marina Kazaryan, Miranush Saaryan, Nerses Ghahramanyan, Artem Oganesyan, Levon Evoyan, Marina Melik-Andreasyan, Anahit Aynajyan, Karapet Hakobyan, Astghik Voskanyan, Karen Meliksetyan, Yervand Hakobyan
Publikováno v:
Regular and Young Investigator Award Abstracts.
HL-443 Expression of CD20 in Classical Hodgkin Lymphoma and its Relationship With CD30, CD15 Markers
Autor:
Iveta Mosesyan, Miranush Saaryan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S349
AML-335: Treating Hematologic Oncology Patients in the Developing World During the COVID-19 Pandemic
Autor:
Artashes Tadevosyan, Armine Farmazyan, Maria Badikyan, Nare Martirosyan, Karen Meliksetyan, Liana Hambardzumyan, Tatevik Grigoryan, Miranush Saaryan, Yervand Hakobyan, Gevorg Tamamyan, Hayk Grigoryan, Samvel Danielyan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia
Context The COVID-19 pandemic has caused healthcare and economic crisis in many countries globally. By 06/08/2020, the number of positive cases in Armenia were 13,325 (∼4,500 per million), with 211 lethal cases. Reports showed that patients with ca
Autor:
Armine Farmazyan, Nare Martirosyan, Anahit Ter-Grigoryan, Samvel Danielyan, Anna Sevoyan, Maria Badikyan, Gevorg Saghumyan, Gevorg Tamamyan, Hayk Grigoryan, Liana Hambardzumyan, Miranush Saaryan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S333-S334
Context: Essential thrombocythemia (ET) is a myeloproliferative neoplasm, with an incidence of 1.2 to 3.0 per 100,000 population per year in the United States, with a median age of 58 years. In developing countries, there are certain diagnostic and t